A pilot trial of consolidation bevacizumab after hypo‐fractionated concurrent chemoradiotherapy in patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer

A pilot trial of consolidation bevacizumab after hypo‐fractionated concurrent chemoradiotherapy in patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer

Abstract Purpose To determine the feasibility of incorporating bevacizumab consolidation into hypo‐fractionated concurrent chemoradiotherapy (hypo‐CCRT) for patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer (LA‐NS‐NSCLC). Patients and Methods Eligible patients were...

Full description

Bibliographic Details
Main Authors: LanQing Huo, Chu Chu, XiaoBo Jiang, ShiYang Zheng, PengXin Zhang, Rui Zhou, NaiBin Chen, JinYu Guo, Bo Qiu, Hui Liu
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Cancer Medicine
Subjects:
consolidation bevacizumab
hypo‐CCRT
LA‐NS‐NSCLC
treatment‐related toxicity
Online Access:https://doi.org/10.1002/cam4.6381

Internet

https://doi.org/10.1002/cam4.6381

Similar Items